A precipitous step deeper into the CDMO business
23/11/20 -"Wacker's Biosolutions business has become a partner of choice for German mRNA player CureVac. Currently, the technology transfer for the production of CureVac's COVID-19 vaccine candidate is being ..."
Pages
49
Language
English
Published on
23/11/20
You may also be interested by these reports :
20/11/25
Johnson Matthey’s H1 2026 results reaffirmed our concerns around softness in Clean Air. While PGM Services benefited from high metal prices, we do ...
19/11/25
Akzo Nobel and Axalta have finally agreed to merge after years of deliberation, likely helped by a sluggish economic backdrop and pressure from ...
18/11/25
KWS’ new growth strategy confirms mid-term targets & raises its dividend payout ratio
12/11/25
1Q25/26: Sales lower but EBITDA better than expected by us as well as by the market – FY25/26E guidance confirmed